MANHATTAN ASSOCIATES INC (MANH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 400M 800M 1.2B FY09: 246.7M FY10: 297.1M FY11: 90.7M FY12: 104.4M FY13: 110.8M FY14: 134.6M FY15: 131.3M FY16: 604.6M FY17: 594.6M FY18: 559.2M FY19: 617.9M FY20: 586.4M FY21: 663.6M FY22: 767.1M FY23: 928.7M FY24: 1B FY25: 1.1B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 250M 500M 750M FY16: 354.7M FY17: 348.9M FY18: 318.3M FY19: 333M FY20: 316.5M FY21: 365.8M FY22: 408.8M FY23: 498.1M FY24: 571.4M FY25: 609.1M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

0 100M 200M 300M FY09: 21.1M FY10: 41.9M FY11: 61.4M FY12: 80.1M FY13: 101.3M FY14: 127.1M FY15: 161.4M FY16: 194.3M FY17: 185.6M FY18: 133.9M FY19: 115.9M FY20: 114.1M FY21: 134.3M FY22: 152.7M FY23: 209.9M FY24: 261.6M FY25: 279.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 80M 160M 240M FY09: 16.6M FY10: 28.1M FY11: 44.9M FY12: 51.9M FY13: 67.3M FY14: 82M FY15: 103.5M FY16: 124.2M FY17: 116.5M FY18: 104.7M FY19: 85.8M FY20: 87.2M FY21: 110.5M FY22: 129M FY23: 176.6M FY24: 218.4M FY25: 219.9M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 200M 400M 600M FY09: 107.5M FY10: 128.8M FY11: 139.1M FY12: 161.7M FY13: 181.2M FY14: 212.6M FY15: 235.4M FY16: 249.9M FY17: 245.7M FY18: 240.9M FY19: 285M FY20: 269.9M FY21: 297.8M FY22: 358.2M FY23: 430.6M FY24: 471M FY25: 472.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 150M 300M 450M FY09: 58.3M FY10: 50M FY11: 55.8M FY12: 75.3M FY13: 89.4M FY14: 94.2M FY15: 120.2M FY16: 139.3M FY17: 164.1M FY18: 137.3M FY19: 146.9M FY20: 140.9M FY21: 185.2M FY22: 179.6M FY23: 246.2M FY24: 295M FY25: 389.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 150M 300M 450M FY09: 55.9M FY10: 44.1M FY11: 50.8M FY12: 67.4M FY13: 84.6M FY14: 84.7M FY15: 108.7M FY16: 132.5M FY17: 157.9M FY18: 130M FY19: 131.7M FY20: 138.2M FY21: 181.2M FY22: 173M FY23: 241.5M FY24: 286.3M FY25: 374M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 30M 60M 90M FY09: 22.6M FY10: 22.4M FY11: 86M FY12: 81.1M FY13: 77.9M FY14: 75.8M FY15: 74M FY16: 72.1M FY17: 69.4M FY18: 66.4M FY19: 65.1M FY20: 64.3M FY21: 64.3M FY22: 63.4M FY23: 62.6M FY24: 62.2M FY25: 61.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '10: 1.25 Q1 '11: 1.25 Q2 '11: 1.46 Q3 '11: 1.88 Q4 '11: 2.09 Q1 '12: 2.32 Q2 '12: 2.45 Q3 '12: 2.44 Q4 '12: 2.10 Q1 '13: 1.72 Q2 '13: 1.24 Q3 '13: 0.80 Q4 '13: 0.86 Q1 '14: 0.93 Q2 '14: 0.98 Q3 '14: 1.03 Q4 '14: 1.08 Q1 '15: 1.15 Q2 '15: 1.23 Q3 '15: 1.31 Q4 '15: 1.40 Q1 '16: 1.47 Q2 '16: 1.58 Q3 '16: 1.67 Q4 '16: 1.73 Q1 '17: 1.75 Q2 '17: 1.74 Q3 '17: 1.74 Q4 '17: 1.68 Q1 '18: 1.61 Q2 '18: 1.58 Q3 '18: 1.54 Q4 '18: 1.58 Q1 '19: 1.57 Q2 '19: 1.47 Q3 '19: 1.46 Q4 '19: 1.32 Q1 '20: 1.35 Q2 '20: 1.33 Q3 '20: 1.30 Q4 '20: 1.36 Q1 '21: 1.36 Q2 '21: 1.54 Q3 '21: 1.72 Q4 '21: 1.72 Q1 '22: 1.85 Q2 '22: 1.86 Q3 '22: 1.76 Q4 '22: 2.04 Q1 '23: 2.18 Q2 '23: 2.32 Q3 '23: 2.64 Q4 '23: 2.81 Q1 '24: 3.05 Q2 '24: 3.27 Q3 '24: 3.51 Q4 '24: 3.51 Q1 '25: 3.50 Q2 '25: 3.58 Q3 '25: 3.51 Q4 '25: 3.59 Q1 '26: 3.56 Q2 '26: 3.48 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.